HedgeChatter

  • Home /
  • Tag Archives

RARE

Ultragenyx reports Q1 EPS (85c), consensus (37c)

moreView todays social media effects on RAREView the latest stocks trending across Twitter. Click to view dashboardSee who Ultragenyx is hiring next, click here to view […]

May 12, 2014 Bystocknews , Comments Off on Ultragenyx reports Q1 EPS (85c), consensus (37c) read more

Ultragenyx Reports First Quarter 2014 Financial Results and Corporate Update

[GlobeNewswire] – NOVATO, Calif. — Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported its financial results and corporate … moreView todays social media effects on RAREView the latest stocks trending across Twitter. Click to view dashboardSee who Ultragenyx is hiring next, click here to view […]

May 12, 2014 Bystocknews , Comments Off on Ultragenyx Reports First Quarter 2014 Financial Results and Corporate Update read more

Ultragenyx Announces Positive Data From Phase 2 Study of Sialic Acid Extended-Release at Emerging Sciences Session of American Academy of Neurology Annual Meeting

[GlobeNewswire] – NOVATO, Calif. — Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the presentation of detailed … moreView todays social media effects on RAREView the latest stocks trending across Twitter. Click to view dashboardSee who Ultragenyx is hiring next, click here to view […]

April 30, 2014 Bystocknews , Comments Off on Ultragenyx Announces Positive Data From Phase 2 Study of Sialic Acid Extended-Release at Emerging Sciences Session of American Academy of Neurology Annual Meeting read more

Ultragenyx to Present at Cowen and Company 34th Annual Health Care Conference in Boston

[GlobeNewswire] – Novato, CA — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Shalini Sharp, … moreView todays social media effects on RAREView the latest stocks trending across Twitter. Click to view dashboardSee who Ultragenyx is hiring next, click here to view […]

February 26, 2014 Bystocknews , Comments Off on Ultragenyx to Present at Cowen and Company 34th Annual Health Care Conference in Boston read more

The case for the bears weakens

moreView todays social media effects on RAREView the latest stocks trending across Twitter. Click to view dashboardSee who Ultragenyx is hiring next, click here to view […]

February 25, 2014 Bystocknews , Comments Off on The case for the bears weakens read more

Ultragenyx Jumps on Positive Patient Data

moreView todays social media effects on RAREView the latest stocks trending across Twitter. Click to view dashboardSee who Ultragenyx is hiring next, click here to view […]

February 13, 2014 Bystocknews , Comments Off on Ultragenyx Jumps on Positive Patient Data read more

9:11 am Ultragenyx Pharma announces presentation of data from a single patient treated with recombinant human beta-glucuronidase at 10th Annual World Lysosomal Disease Network Symposium; Preliminary data showed a reduction in lysosomal stor

moreView todays social media effects on RAREView the latest stocks trending across Twitter. Click to view dashboardSee who Ultragenyx is hiring next, click here to view […]

February 12, 2014 Bystocknews , Comments Off on 9:11 am Ultragenyx Pharma announces presentation of data from a single patient treated with recombinant human beta-glucuronidase at 10th Annual World Lysosomal Disease Network Symposium; Preliminary data showed a reduction in lysosomal stor read more

Ultragenyx Announces Presentation of Data From a Single Patient Treated With Recombinant Human Beta-Glucuronidase at 10th Annual World Lysosomal Disease Network Symposium

[GlobeNewswire] – NOVATO, Calif. — Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced data presentations from a single … moreView todays social media effects on RAREView the latest stocks trending across Twitter. Click to view dashboardSee who Ultragenyx is hiring next, click here to view […]

February 12, 2014 Bystocknews , Comments Off on Ultragenyx Announces Presentation of Data From a Single Patient Treated With Recombinant Human Beta-Glucuronidase at 10th Annual World Lysosomal Disease Network Symposium read more